(Q61716910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Etiology and response to drug treatment in heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

F Follath

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

W Klein

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

R Murphy

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

English

0 references

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

1167-1172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

Epidemiologic patterns, clinical evaluation, and long-term prognosis in chronic congestive heart failure

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Frequency of familial dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Anti-beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Adrenergic effects on the biology of the adult mammalian cardiocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Cardiac myocyte necrosis induced by angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Oxidative stress and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Oxygen free radicals and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Elevated breath pentane in heart failure reduced by free radical scavenger.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Endothelial injury and coronary vasomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: differences between patients with primary cardiomyopathy, chronic coronary artery disease, or acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Relation between gender, etiology and survival in patients with symptomatic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Impact of medical therapy on pulmonary hypertension in patients with congestive heart failure awaiting cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Prognosis of idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Patients with mild heart failure worsen during withdrawal from digoxin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Beta-blocking agents in heart failure. Should they be used and how?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Amlodipine in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900400-8

7 January 2021

10.1016/S0735-1097(98)00400-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9809921%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference